at Nasdaq.com (Jan 21, 2015)
Shares of Nu Skin (NUS -8.7%) are getting hit today on a Citron Research report accusing the company of being in violation of "direct selling" rules in China, putting their entire Chinese business operation "in jeopardy of seizure." Citron notes that NUS' China business comprised almost 75% of its Y/Y revenue growth in Q2, making the risk of its China operations coming to an abrupt halt massive, and the consequences devastating. Herbalife (HLF -1.7%) and Usana Health Services (USNA -3.7%) also trade down on the report.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Nasdaq.com (Jan 13, 2015)
at Zacks.com (Jan 8, 2015)
at Zacks.com (Dec 30, 2014)
at Zacks.com (Dec 18, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs